Pfizer Stock Slipped 1.53% after Posting Financial Results

Tiger Newspress2022-05-03

Pfizer stock slipped 1.53% after posting financial results.

Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.

Revenue of $25.7B (+77.0% Y/Y) beats by $970M.

Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally

Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts

Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange

Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange

Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&D Expenses in Adjusted Results

Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Calvin_GKH
2022-05-04
Calvin_GKH
Omg
KCtan1688
2022-05-04
KCtan1688
Like
Remotecam
2022-05-03
Remotecam
$Pfizer(PFE)$stock downtrend, driven only by market makers sentiment that the covid pandamic record earnings is over and it's time to leave. Outflow would have been worse if they missed estimates.
WJ77
2022-05-03
WJ77
🤔🤔
JarenSin
2022-05-03
JarenSin
It will still go up nevertheless.
KPTan
2022-05-03
KPTan
Tq for sharing

Leave a comment

182

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1196919160?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-05-03 18:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196919160","market":"us","top_or_hot":-1,"title":"Pfizer Stock Slipped 1.53% after Posting Financial Results","media":"Tiger Newspress","content":"<html><head></head><body><p>Pfizer stock slipped 1.53% after posting financial results.</p><p><img src=\"https://static.tigerbbs.com/9a67f357bf458d80154ec51ae25f5222\" tg-width=\"890\" tg-height=\"716\" width=\"100%\" height=\"auto\"/></p><p>Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.</p><p>Revenue of $25.7B (+77.0% Y/Y) beats by $970M.</p><p>Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally</p><p>Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts</p><p>Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange</p><p>Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange</p><p>Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&amp;D Expenses in Adjusted Results</p><p>Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.</p><p></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Stock Slipped 1.53% after Posting Financial Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Stock Slipped 1.53% after Posting Financial Results\n</h2>\n\n<h4 class=\"meta\">\n\n2022-05-03 18:53 北京时间&nbsp;&nbsp;&nbsp;<strong>Tiger Newspress</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.Revenue of $25.7B (+77.0% Y/Y) beats by $970M.Reflecting 82% Operational Growth; Excluding ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"","article_id":"1196919160","we_media_id":"1079075236","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196919160","pubTimestamp":1651575204,"sourceInfo":null,"weMediaInfo":{"media_name":"Tiger Newspress","introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞"},"translate_title":"辉瑞公司公布财报后股价下跌1.53%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":0.9},"content_text":"Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.Revenue of $25.7B (+77.0% Y/Y) beats by $970M.Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% OperationallyReaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange ImpactsReaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign ExchangeReaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign ExchangeFull-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&D Expenses in Adjusted ResultsOperational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9061871967,"gmtCreate":1651619220698,"gmtModify":1676534934842,"author":{"id":"3583232588242926","authorId":"3583232588242926","name":"Calvin_GKH","avatar":"https://static.tigerbbs.com/562335042bbb987f5b9370e6664fc2dc","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3583232588242926","authorIdStr":"3583232588242926"},"htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9061871967","repostId":1196919160,"repostType":4,"repost":{"id":"1196919160","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1651575204,"share":"https://ttm.financial/m/news/1196919160?lang=&edition=fundamental","pubTime":"2022-05-03 18:53","market":"us","language":"en","title":"Pfizer Stock Slipped 1.53% after Posting Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1196919160","media":"Tiger Newspress","summary":"Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by ","content":"<html><head></head><body><p>Pfizer stock slipped 1.53% after posting financial results.</p><p><img src=\"https://static.tigerbbs.com/9a67f357bf458d80154ec51ae25f5222\" tg-width=\"890\" tg-height=\"716\" width=\"100%\" height=\"auto\"/></p><p>Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.</p><p>Revenue of $25.7B (+77.0% Y/Y) beats by $970M.</p><p>Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally</p><p>Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts</p><p>Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange</p><p>Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange</p><p>Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&amp;D Expenses in Adjusted Results</p><p>Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Stock Slipped 1.53% after Posting Financial Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Stock Slipped 1.53% after Posting Financial Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-05-03 18:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Pfizer stock slipped 1.53% after posting financial results.</p><p><img src=\"https://static.tigerbbs.com/9a67f357bf458d80154ec51ae25f5222\" tg-width=\"890\" tg-height=\"716\" width=\"100%\" height=\"auto\"/></p><p>Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.</p><p>Revenue of $25.7B (+77.0% Y/Y) beats by $970M.</p><p>Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally</p><p>Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts</p><p>Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange</p><p>Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange</p><p>Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&amp;D Expenses in Adjusted Results</p><p>Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196919160","content_text":"Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.Revenue of $25.7B (+77.0% Y/Y) beats by $970M.Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% OperationallyReaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange ImpactsReaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign ExchangeReaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign ExchangeFull-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&D Expenses in Adjusted ResultsOperational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9061818937,"gmtCreate":1651611688707,"gmtModify":1676534933391,"author":{"id":"3572830110372716","authorId":"3572830110372716","name":"KCtan1688","avatar":"https://static.tigerbbs.com/eb264e77c49fffb1d26a89a47dbc0250","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3572830110372716","authorIdStr":"3572830110372716"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9061818937","repostId":1196919160,"repostType":4,"repost":{"id":"1196919160","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1651575204,"share":"https://ttm.financial/m/news/1196919160?lang=&edition=fundamental","pubTime":"2022-05-03 18:53","market":"us","language":"en","title":"Pfizer Stock Slipped 1.53% after Posting Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1196919160","media":"Tiger Newspress","summary":"Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by ","content":"<html><head></head><body><p>Pfizer stock slipped 1.53% after posting financial results.</p><p><img src=\"https://static.tigerbbs.com/9a67f357bf458d80154ec51ae25f5222\" tg-width=\"890\" tg-height=\"716\" width=\"100%\" height=\"auto\"/></p><p>Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.</p><p>Revenue of $25.7B (+77.0% Y/Y) beats by $970M.</p><p>Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally</p><p>Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts</p><p>Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange</p><p>Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange</p><p>Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&amp;D Expenses in Adjusted Results</p><p>Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Stock Slipped 1.53% after Posting Financial Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Stock Slipped 1.53% after Posting Financial Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-05-03 18:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Pfizer stock slipped 1.53% after posting financial results.</p><p><img src=\"https://static.tigerbbs.com/9a67f357bf458d80154ec51ae25f5222\" tg-width=\"890\" tg-height=\"716\" width=\"100%\" height=\"auto\"/></p><p>Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.</p><p>Revenue of $25.7B (+77.0% Y/Y) beats by $970M.</p><p>Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally</p><p>Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts</p><p>Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange</p><p>Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange</p><p>Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&amp;D Expenses in Adjusted Results</p><p>Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196919160","content_text":"Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.Revenue of $25.7B (+77.0% Y/Y) beats by $970M.Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% OperationallyReaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange ImpactsReaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign ExchangeReaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign ExchangeFull-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&D Expenses in Adjusted ResultsOperational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9061170331,"gmtCreate":1651591196115,"gmtModify":1676534932373,"author":{"id":"4093854476996450","authorId":"4093854476996450","name":"Remotecam","avatar":"https://community-static.tradeup.com/news/f856a0a30bd0fa23a086fc678014e48b","vip":1,"crmLevel":6,"crmLevelSwitch":1,"idStr":"4093854476996450","authorIdStr":"4093854476996450"},"htmlText":"<a href=\"https://ttm.financial/S/PFE\">$Pfizer(PFE)$</a>stock downtrend, driven&nbsp;only by market makers sentiment that the covid pandamic&nbsp;record earnings&nbsp;is over and it's time to leave.&nbsp; Outflow would have been worse if they missed estimates.","listText":"<a href=\"https://ttm.financial/S/PFE\">$Pfizer(PFE)$</a>stock downtrend, driven&nbsp;only by market makers sentiment that the covid pandamic&nbsp;record earnings&nbsp;is over and it's time to leave.&nbsp; Outflow would have been worse if they missed estimates.","text":"$Pfizer(PFE)$stock downtrend, driven only by market makers sentiment that the covid pandamic record earnings is over and it's time to leave. Outflow would have been worse if they missed estimates.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9061170331","repostId":1196919160,"repostType":4,"repost":{"id":"1196919160","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1651575204,"share":"https://ttm.financial/m/news/1196919160?lang=&edition=fundamental","pubTime":"2022-05-03 18:53","market":"us","language":"en","title":"Pfizer Stock Slipped 1.53% after Posting Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1196919160","media":"Tiger Newspress","summary":"Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by ","content":"<html><head></head><body><p>Pfizer stock slipped 1.53% after posting financial results.</p><p><img src=\"https://static.tigerbbs.com/9a67f357bf458d80154ec51ae25f5222\" tg-width=\"890\" tg-height=\"716\" width=\"100%\" height=\"auto\"/></p><p>Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.</p><p>Revenue of $25.7B (+77.0% Y/Y) beats by $970M.</p><p>Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally</p><p>Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts</p><p>Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange</p><p>Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange</p><p>Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&amp;D Expenses in Adjusted Results</p><p>Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Stock Slipped 1.53% after Posting Financial Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Stock Slipped 1.53% after Posting Financial Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-05-03 18:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Pfizer stock slipped 1.53% after posting financial results.</p><p><img src=\"https://static.tigerbbs.com/9a67f357bf458d80154ec51ae25f5222\" tg-width=\"890\" tg-height=\"716\" width=\"100%\" height=\"auto\"/></p><p>Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.</p><p>Revenue of $25.7B (+77.0% Y/Y) beats by $970M.</p><p>Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally</p><p>Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts</p><p>Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange</p><p>Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange</p><p>Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&amp;D Expenses in Adjusted Results</p><p>Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196919160","content_text":"Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.Revenue of $25.7B (+77.0% Y/Y) beats by $970M.Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% OperationallyReaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange ImpactsReaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign ExchangeReaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign ExchangeFull-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&D Expenses in Adjusted ResultsOperational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9061169061,"gmtCreate":1651587050803,"gmtModify":1676534931241,"author":{"id":"3573616695330925","authorId":"3573616695330925","name":"WJ77","avatar":"https://static.tigerbbs.com/56bf6bd5b462948ac1028ecaabdba952","vip":1,"crmLevel":9,"crmLevelSwitch":1,"idStr":"3573616695330925","authorIdStr":"3573616695330925"},"htmlText":"🤔🤔","listText":"🤔🤔","text":"🤔🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9061169061","repostId":1196919160,"repostType":4,"repost":{"id":"1196919160","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1651575204,"share":"https://ttm.financial/m/news/1196919160?lang=&edition=fundamental","pubTime":"2022-05-03 18:53","market":"us","language":"en","title":"Pfizer Stock Slipped 1.53% after Posting Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1196919160","media":"Tiger Newspress","summary":"Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by ","content":"<html><head></head><body><p>Pfizer stock slipped 1.53% after posting financial results.</p><p><img src=\"https://static.tigerbbs.com/9a67f357bf458d80154ec51ae25f5222\" tg-width=\"890\" tg-height=\"716\" width=\"100%\" height=\"auto\"/></p><p>Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.</p><p>Revenue of $25.7B (+77.0% Y/Y) beats by $970M.</p><p>Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally</p><p>Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts</p><p>Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange</p><p>Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange</p><p>Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&amp;D Expenses in Adjusted Results</p><p>Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Stock Slipped 1.53% after Posting Financial Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Stock Slipped 1.53% after Posting Financial Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-05-03 18:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Pfizer stock slipped 1.53% after posting financial results.</p><p><img src=\"https://static.tigerbbs.com/9a67f357bf458d80154ec51ae25f5222\" tg-width=\"890\" tg-height=\"716\" width=\"100%\" height=\"auto\"/></p><p>Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.</p><p>Revenue of $25.7B (+77.0% Y/Y) beats by $970M.</p><p>Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally</p><p>Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts</p><p>Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange</p><p>Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange</p><p>Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&amp;D Expenses in Adjusted Results</p><p>Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196919160","content_text":"Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.Revenue of $25.7B (+77.0% Y/Y) beats by $970M.Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% OperationallyReaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange ImpactsReaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign ExchangeReaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign ExchangeFull-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&D Expenses in Adjusted ResultsOperational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9061136930,"gmtCreate":1651583826756,"gmtModify":1676534930553,"author":{"id":"3574228744527117","authorId":"3574228744527117","name":"JarenSin","avatar":"https://static.tigerbbs.com/34e62412266232d31a80955037ebc419","vip":1,"hat":"https://static.tigerbbs.com/c5ad23bb360296300b77bdc994657095","crmLevel":2,"crmLevelSwitch":0,"idStr":"3574228744527117","authorIdStr":"3574228744527117"},"htmlText":"It will still go up nevertheless.","listText":"It will still go up nevertheless.","text":"It will still go up nevertheless.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9061136930","repostId":1196919160,"repostType":4,"repost":{"id":"1196919160","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1651575204,"share":"https://ttm.financial/m/news/1196919160?lang=&edition=fundamental","pubTime":"2022-05-03 18:53","market":"us","language":"en","title":"Pfizer Stock Slipped 1.53% after Posting Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1196919160","media":"Tiger Newspress","summary":"Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by ","content":"<html><head></head><body><p>Pfizer stock slipped 1.53% after posting financial results.</p><p><img src=\"https://static.tigerbbs.com/9a67f357bf458d80154ec51ae25f5222\" tg-width=\"890\" tg-height=\"716\" width=\"100%\" height=\"auto\"/></p><p>Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.</p><p>Revenue of $25.7B (+77.0% Y/Y) beats by $970M.</p><p>Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally</p><p>Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts</p><p>Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange</p><p>Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange</p><p>Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&amp;D Expenses in Adjusted Results</p><p>Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Stock Slipped 1.53% after Posting Financial Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Stock Slipped 1.53% after Posting Financial Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-05-03 18:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Pfizer stock slipped 1.53% after posting financial results.</p><p><img src=\"https://static.tigerbbs.com/9a67f357bf458d80154ec51ae25f5222\" tg-width=\"890\" tg-height=\"716\" width=\"100%\" height=\"auto\"/></p><p>Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.</p><p>Revenue of $25.7B (+77.0% Y/Y) beats by $970M.</p><p>Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally</p><p>Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts</p><p>Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange</p><p>Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange</p><p>Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&amp;D Expenses in Adjusted Results</p><p>Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196919160","content_text":"Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.Revenue of $25.7B (+77.0% Y/Y) beats by $970M.Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% OperationallyReaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange ImpactsReaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign ExchangeReaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign ExchangeFull-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&D Expenses in Adjusted ResultsOperational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9061190584,"gmtCreate":1651581609448,"gmtModify":1676534930217,"author":{"id":"4089242101506430","authorId":"4089242101506430","name":"KPTan","avatar":"https://static.tigerbbs.com/6d16c608c834afdaf5cdb810b6196a28","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4089242101506430","authorIdStr":"4089242101506430"},"htmlText":"Tq for sharing","listText":"Tq for sharing","text":"Tq for sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9061190584","repostId":1196919160,"repostType":4,"repost":{"id":"1196919160","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1651575204,"share":"https://ttm.financial/m/news/1196919160?lang=&edition=fundamental","pubTime":"2022-05-03 18:53","market":"us","language":"en","title":"Pfizer Stock Slipped 1.53% after Posting Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1196919160","media":"Tiger Newspress","summary":"Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by ","content":"<html><head></head><body><p>Pfizer stock slipped 1.53% after posting financial results.</p><p><img src=\"https://static.tigerbbs.com/9a67f357bf458d80154ec51ae25f5222\" tg-width=\"890\" tg-height=\"716\" width=\"100%\" height=\"auto\"/></p><p>Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.</p><p>Revenue of $25.7B (+77.0% Y/Y) beats by $970M.</p><p>Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally</p><p>Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts</p><p>Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange</p><p>Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange</p><p>Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&amp;D Expenses in Adjusted Results</p><p>Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Stock Slipped 1.53% after Posting Financial Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Stock Slipped 1.53% after Posting Financial Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-05-03 18:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Pfizer stock slipped 1.53% after posting financial results.</p><p><img src=\"https://static.tigerbbs.com/9a67f357bf458d80154ec51ae25f5222\" tg-width=\"890\" tg-height=\"716\" width=\"100%\" height=\"auto\"/></p><p>Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.</p><p>Revenue of $25.7B (+77.0% Y/Y) beats by $970M.</p><p>Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally</p><p>Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts</p><p>Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange</p><p>Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange</p><p>Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&amp;D Expenses in Adjusted Results</p><p>Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196919160","content_text":"Pfizer stock slipped 1.53% after posting financial results.Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.Revenue of $25.7B (+77.0% Y/Y) beats by $970M.Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% OperationallyReaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange ImpactsReaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign ExchangeReaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign ExchangeFull-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&D Expenses in Adjusted ResultsOperational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":182,"commentSize":25,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1196919160"}